# Avo

> Avo's April 2026 Series A highlights investor demand for AI systems that integrate directly into clinical workflows.

## Why it is interesting

Clinical teams manage fragmented data, billing constraints, and documentation burden, all of which reduce time for direct patient care. Healthcare providers continue to adopt AI tools that can improve workflow efficiency without creating additional compliance risk. Avo's April 2026 Series A highlights investor demand for AI systems that integrate directly into clinical workflows.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** ai-ml, fintech, healthtech, enterprise-saas
- **Coverage:** full
- **Last updated:** 2026-04-06

## Key facts

- Disclosed financing: $10M (Series A)
- Covered in 1 Venture Capital Tracker article(s)

## Related articles

- https://venturecapitaltracker.com/2026-avo-10m-series-a-clinical-ai

---
Source: https://venturecapitaltracker.com/startup/avo
